CY1121234T1 - Μεθοδος για μη-επεμβατικη προγεννητικη ανιχνευση του ευπλοιδικου εμβυικου χρωμοσωματος απο το μητρικο αιμα - Google Patents

Μεθοδος για μη-επεμβατικη προγεννητικη ανιχνευση του ευπλοιδικου εμβυικου χρωμοσωματος απο το μητρικο αιμα

Info

Publication number
CY1121234T1
CY1121234T1 CY20191100168T CY191100168T CY1121234T1 CY 1121234 T1 CY1121234 T1 CY 1121234T1 CY 20191100168 T CY20191100168 T CY 20191100168T CY 191100168 T CY191100168 T CY 191100168T CY 1121234 T1 CY1121234 T1 CY 1121234T1
Authority
CY
Cyprus
Prior art keywords
processing
samples
value
invasive
alternative
Prior art date
Application number
CY20191100168T
Other languages
English (en)
Inventor
Frantisek DURIS
Jaroslav BUDIS
Tomás SZEMES
Gabriel MINÁRIK
Original Assignee
Trisomytest, S.R.O.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Trisomytest, S.R.O. filed Critical Trisomytest, S.R.O.
Publication of CY1121234T1 publication Critical patent/CY1121234T1/el

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6809—Methods for determination or identification of nucleic acids involving differential detection
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B20/00—ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
    • G16B20/10—Ploidy or copy number detection
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B20/00—ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B20/00—ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
    • G16B20/20—Allele or variant detection, e.g. single nucleotide polymorphism [SNP] detection
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B30/00—ICT specially adapted for sequence analysis involving nucleotides or amino acids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Analytical Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Theoretical Computer Science (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Medical Informatics (AREA)
  • Evolutionary Biology (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)

Abstract

Η παρούσα εφεύρεση παρέχει μια εναλλακτική και αξιόπιστη μέθοδο η οποία εφαρμόζεται τουλάχιστον στην πρακτική της μη επεμβατικής προγεννητικής διαλογής για ανευπλοειδίες, όπως τρισωμίες ή μονοσώματα, κατά προτίμηση για την τρισωμία του χρωμοσώματος 13, 18 ή 21. Λόγω της νέας και εφευρετικής προσέγγισης, αυτή η μέθοδος παρέχει μια εναλλακτική μέθοδο τιμής z, η οποία προσφέρει καλύτερη διάκριση μεταξύ των δειγμάτων ευπλοϊδίας και ανευπλοειδίας, δηλ. βελτιώνει την αξιοπιστία της δοκιμασίας. Επιπλέον, η μέθοδος απαιτεί σχετικά χαμηλή ποσότητα δεδομένων αλληλουχίας και ως εκ τούτου μια τέτοια μέθοδος είναι σχετικά φθηνή και θα ήταν προσιτή ακόμη και για μικρά ιδρύματα υγειονομικής περίθαλψης. Η μέθοδος περιλαμβάνει τέσσερα κύρια στάδια: 1) λήψη και επεξεργασία δειγμάτων μητρικού αίματος, 2) παρασκευή δείγματος DNA και βιβλιοθήκης DNA, 3) αλληλούχιση και 4) επεξεργασία των δεδομένων αλληλουχίας για να ληφθεί μια τιμή που έχει μια προγνωστική σημασία. Το ουσιώδες μέρος της μεθόδου είναι η προετοιμασία και η επεξεργασία των δεδομένων εκπαίδευσης, δηλ. την επεξεργασία του συνόλου των ευπλοοειδών δειγμάτων που υποβάλλονται σε επεξεργασία με τον ίδιο τρόπο όπως τα δείγματα δοκιμής. Τα αποτελέσματα της επεξεργασίας των δειγμάτων μελέτης χρησιμεύουν ως δεδομένα αναφοράς στο βήμα 4.
CY20191100168T 2016-06-23 2019-02-07 Μεθοδος για μη-επεμβατικη προγεννητικη ανιχνευση του ευπλοιδικου εμβυικου χρωμοσωματος απο το μητρικο αιμα CY1121234T1 (el)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/EP2016/064604 WO2017220156A1 (en) 2016-06-23 2016-06-23 A method for non-invasive prenatal detection of fetal chromosome aneuploidy from maternal blood

Publications (1)

Publication Number Publication Date
CY1121234T1 true CY1121234T1 (el) 2020-05-29

Family

ID=56345095

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20191100168T CY1121234T1 (el) 2016-06-23 2019-02-07 Μεθοδος για μη-επεμβατικη προγεννητικη ανιχνευση του ευπλοιδικου εμβυικου χρωμοσωματος απο το μητρικο αιμα

Country Status (14)

Country Link
EP (1) EP3283647B1 (el)
CY (1) CY1121234T1 (el)
DK (1) DK3283647T3 (el)
EA (1) EA201990098A1 (el)
ES (1) ES2708376T3 (el)
HR (1) HRP20190168T1 (el)
HU (1) HUE042012T2 (el)
LT (1) LT3283647T (el)
PL (1) PL3283647T3 (el)
PT (1) PT3283647T (el)
RS (1) RS58364B1 (el)
RU (1) RU2744604C2 (el)
SI (1) SI3283647T1 (el)
WO (1) WO2017220156A1 (el)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2942400A1 (en) 2014-05-09 2015-11-11 Lifecodexx AG Multiplex detection of DNA that originates from a specific cell-type
MA39951A (fr) 2014-05-09 2017-03-15 Lifecodexx Ag Détection de l'adn provenant d'un type spécifique de cellule et méthodes associées
DK3168309T3 (da) 2015-11-10 2020-06-22 Eurofins Lifecodexx Gmbh Detektion af føtale kromosomale aneuploidier under anvendelse af dna-regioner med forskellig metylering mellem fosteret og det gravide hunkøn
WO2019227420A1 (zh) * 2018-05-31 2019-12-05 深圳华大临床检验中心 确定男性待测样本是否存在三倍体的方法、系统和计算机可读介质

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050277147A1 (en) * 2004-06-11 2005-12-15 Ameet Patki Identifying chromosomal abnormalities in cells obtained from follicular fluid

Also Published As

Publication number Publication date
HUE042012T2 (hu) 2019-06-28
PT3283647T (pt) 2019-02-11
HRP20190168T1 (hr) 2019-03-22
ES2708376T3 (es) 2019-04-09
DK3283647T3 (en) 2018-12-17
RU2744604C2 (ru) 2021-03-11
RU2017104533A (ru) 2020-05-12
EA201990098A1 (ru) 2019-05-31
RU2017104533A3 (el) 2020-05-12
EP3283647A1 (en) 2018-02-21
LT3283647T (lt) 2019-02-25
PL3283647T3 (pl) 2019-05-31
EP3283647B1 (en) 2018-11-07
RS58364B1 (sr) 2019-03-29
SI3283647T1 (sl) 2019-03-29
WO2017220156A1 (en) 2017-12-28

Similar Documents

Publication Publication Date Title
CY1121234T1 (el) Μεθοδος για μη-επεμβατικη προγεννητικη ανιχνευση του ευπλοιδικου εμβυικου χρωμοσωματος απο το μητρικο αιμα
Velissaris et al. C-reactive protein and frailty in the elderly: a literature review
Beltran Valls et al. Protein carbonylation and heat shock proteins in human skeletal muscle: relationships to age and sarcopenia
Bacalini et al. A meta-analysis on age-associated changes in blood DNA methylation: results from an original analysis pipeline for Infinium 450k data
BR112016027848A2 (pt) Método para avaliação de número de cópias de uma sequência de interesse, meio legível por máquina não transitória, e, sistema para avaliação de número de cópias de uma sequência de interesse
BR112017025297A2 (pt) anticorpos anti-gitr para diagnóstico do câncer
EP4282405A3 (en) Detection of cancer biomarkers using nanoparticles
Vilahur et al. Storage conditions and stability of global DNA methylation in placental tissue
EP3171288A1 (en) Method for prediction of fetal monogenic genetic variations using maternal serum dna
BR112014029233A8 (pt) método para diagnosticar se um indivíduo grávido não está em risco, usos de pelo menos um dos biomarcadores sfit-1, endoglina e pigf, dispositivo, kit, método de gestão de um indivíduo, sistema e método para estabelecer um auxílio
AR111114A1 (es) Ensayo no destructivo para semillas de soja usando análisis de infrarrojo cercano
Bouvier et al. Preanalytical, analytical, gestational and pediatric aspects of the S100B immuno-assays
Macías et al. The Dynamic Use of EGFR Mutation Analysis in Cell‐Free DNA as a Follow‐Up Biomarker during Different Treatment Lines in Non‐Small‐Cell Lung Cancer Patients
CY1124409T1 (el) Μεθοδος μη επεμβατικης προγεννητικης ανιχνευσης της ανευπλοειδιας του εμβρυικου χρωμοσωματος απο το μητρικο αιμα με βαση τη μεθοδο του βayes
MX2022008215A (es) Peptidos antigenicos y usos de los mismos para diagnosticar y tratar el autismo.
WO2016198833A3 (en) Methods for analysing a urine sample
MX2023007818A (es) Analisis del factor de transcripcion circulante.
Molina-Vila Liquid biopsy in lung cancer: present and future
Sacher et al. Prospective validation of rapid plasma genotyping as a sensitive and specific tool for guiding lung cancer care
CN107723343A (zh) 一种基因定量分析的方法
Bregenzer et al. Tumor modeling maintains diverse pathology in vitro
Hybsier et al. Establishment and characterization of a new ELISA for selenoprotein P
RU2016152686A (ru) Способ определения источника анеуплоидных клеток по крови беременной женщины
BR112020024646A2 (pt) métodos para gerar impressão digital de amostras biológicas
Yamamoto et al. Cell-Free DNA